These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7172473)

  • 1. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
    Tönshoff B; Lehnert W; Ropers HH
    Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of female carriers of adrenoleukodystrophy.
    Moser HW; Moser AE; Trojak JE; Supplee SW
    J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe.
    Boué J; Oberle I; Heilig R; Mandel JL; Moser A; Moser H; Larsen JW; Dumez Y; Boué A
    Hum Genet; 1985; 69(3):272-4. PubMed ID: 3856557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
    Watkins PA; Naidu S; Moser HW
    J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
    Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
    Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier detection for adrenoleukodystrophy by high-performance liquid chromatography.
    Sakai T; Antoku Y; Tsukamoto K; Imanishi K; Iwashita H; Gotoh I
    Exp Neurol; 1988 Jun; 100(3):556-62. PubMed ID: 3366206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
    Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
    Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
    Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
    Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenoleukodystrophy.
    Lenard HG
    Neuropediatrics; 1984 Sep; 15 Suppl():16-9. PubMed ID: 6100794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
    Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
    Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW; Moser AE; Singh I; O'Neill BP
    Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging compared with computed tomography in adrenoleukodystrophy.
    Huckman MS; Wong PW; Sullivan T; Zeller P; Geremia GK
    Am J Dis Child; 1986 Oct; 140(10):1001-3. PubMed ID: 3752010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I; Moser AE; Moser HW; Kishimoto Y
    Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
    Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
    O'Neill BP; Moser HW; Saxena KM; Marmion LC
    Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy.
    O'Neill BP; Moser HW
    Can J Neurol Sci; 1982 Nov; 9(4):449-52. PubMed ID: 6758925
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
    Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
    J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
    Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
    J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy mimicking multiple sclerosis.
    Dooley JM; Wright BA
    Can J Neurol Sci; 1985 Feb; 12(1):73-4. PubMed ID: 3978476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.